Bromocriptine-Mesilate shortage — US supply status & alternatives

Bromocriptine-Mesilate

ATC G02CB01

In supply · Australia

PARLODEL bromocriptine

In supply · 🇦🇺 Australia · short in🇺🇸 US🇫🇷 FR

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Bromocriptine-Mesilate

ATC level 5	G02CB01

ATC level 4	G02CB

Therapeutic category	Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper

Controlled substance	No

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 2 resolved events

◷

~1 month

Historical pattern from resolved shortage records — not a prediction of this event.

Shortage status by regulator official notices

🇺🇸

United States

FDA MedWatch · 3mo ago

High

🇫🇷

France

ANSM · 5d ago

Medium

🇦🇺

Australia

TGA · 24d ago

Resolved

Recalls official enforcement reports

🇺🇸

Bromocriptine Mesylate Active Pharmaceutical Ingredient Pack

Attix Pharmaceuticals · Nov 2014

Class IIdetails ↗

Verified timeline regulator events

🇫🇷 10 Apr 2026

Shortage resolved

🇫🇷 9 Apr 2026

medium reported

🇫🇷 13 Mar 2026

medium reported

🇦🇺 2 Feb 2026

Shortage resolved

🇺🇸 23 Oct 2025

high reported

Sources official regulators

🇫🇷

ANSM

verified 5d ago

verify ↗

🇦🇺

TGA

verified 24d ago

verify ↗

🇺🇸

FDA MedWatch

verified 3mo ago

verify ↗

Mederti Drug Report

Generated 3 July 2026 · Australia market · 3 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.